Gold(I) triphenylphosphine complexes incorporating pentaarylfulleride ligands.

Inorg Chem

Department of Chemistry and Biochemistry, University of California, Los Angeles, California 90095-1569, USA.

Published: May 2010

Two gold(I) complexes, (Ph(3)P)Au[C(60)(4-MeC(6)H(4))(5)] (1) and (Ph(3)P)Au[C(60)(4-t-BuC(6)H(4))(5)] (2), were prepared in excellent yield and characterized by single-crystal X-ray diffraction. Complex 1, grown from two solvent systems, has different coordination modes of the fullerene-embedded Cp ring to the (PPh(3))Au fragment. For 1.(ODCB)(2), the cyclopentadienyl ring coordinates to the (Ph(3)P)Au fragment in an eta(1) fashion distorted toward eta(3) geometry, while in 1.(CHCl(3))(2)(CS(2)), crystal packing forces produce enough distortion to give near eta(2) coordination.

Download full-text PDF

Source
http://dx.doi.org/10.1021/ic100428fDOI Listing

Publication Analysis

Top Keywords

goldi triphenylphosphine
4
triphenylphosphine complexes
4
complexes incorporating
4
incorporating pentaarylfulleride
4
pentaarylfulleride ligands
4
ligands goldi
4
goldi complexes
4
complexes ph3pau[c604-mec6h45]
4
ph3pau[c604-mec6h45] ph3pau[c604-t-buc6h45]
4
ph3pau[c604-t-buc6h45] prepared
4

Similar Publications

The templating properties of a diaza-nickel--dithiolate towards triphenylphosphine gold(I), yielding a [Ni(NS)·2Au(PPh)] complex (T. A. Pinder, S.

View Article and Find Full Text PDF

To study the effect of a dye on the photoluminescence (PL) properties of metal complexes, a series of gold(I) complexes were synthesized, containing a 7-amino-4-methylcoumarin luminophore. The complexes are comprised of a coumarin moiety featuring different ancillary ligands, specifically N-heterocyclic carbenes, triphenylphosphine, and diphenyl-2-pyridylphosphine. The synthesized gold(I) complexes are luminescent both in solution and the solid state at room temperature and 77 K.

View Article and Find Full Text PDF

A diverse family of heterobimetallic bridging hydride adducts of the type [LAu(μ-H)MCp][X] (L = 1,3-bis(2,6-diisopropylphenyl)imidazole-2-ylidene, IPr; 1,3-bis(1-adamantyl)imidazole-2-ylidene, IAd; 1,3-bis(2,6-di--propylphenyl)-5,5-dimethyl-4,6-diketopyrimidinyl-2-ylidene, DAC; triphenylphosphine, PPh; 2-di--butylphosphino-2',4',6'-triisopropylbiphenyl, XPhos; X = SbF, BF or TfO) was synthesized by reacting group VI metallocene dihydrides CpMH (Cp = cyclopentadienyl anion; M = Mo, W) with cationic gold(I) complexes [LAu(NCMe)][X]. Trimetallic [L'Au(μ-H)WCp][X] and tetrametallic [L'Au{(μ-H)WCp}] [X] complexes (L' = -2,2'-bis(diphenylphosphino)-1,1'-binaphthalene or bis(diphenylphosphinomethane)) were obtained by reacting digold [L'{Au(NCMe)}][X] with CpWH in a 1:1 and a 1:2 stoichiometry. Accessing such a broad structural diversity allowed us to pinpoint roles played by the ancillary ligands and group VI metals on the bonding properties of this family of bridging hydrides.

View Article and Find Full Text PDF

Mono- and Dinuclear Gold(I) Coumarin Complexes: Luminescence Studies and Singlet Oxygen Production.

Chempluschem

March 2023

Departament de Química Inorgànica i Orgànica, Secció de Química Inorgànica, Universitat de Barcelona, Martí i Franquès 1-11, 08028, Barcelona, Spain.

The 4-(thiolmethyl)-7-(diethylamino)-2H-chromen-2-one ligand has been synthesized and used as chromophore in several mono- and dinuclear gold(I) compounds that contain a phosphane at the second coordination position. Four final products were able to obtain in pure form containing one coumarin and one phosphane ligand in the case of PTA (1,3,5-triaza-7-phosphatricyclo[3.3.

View Article and Find Full Text PDF

The anti-breast cancer stem cell (CSC) properties of a series of gold(i) complexes comprising various non-steroidal anti-inflammatory drugs (NSAIDs) and triphenylphosphine 1-8 are reported. The most effective gold(i)-NSAID complex 1, containing indomethacin, exhibits greater potency for breast CSCs than bulk breast cancer cells (up to 80-fold). Furthermore, 1 reduces mammosphere viability to a better extent than a panel of clinically used breast cancer drugs and salinomycin, an established anti-breast CSC agent.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!